Medical device companies across Medical Alley are deploying AI tools into their operations. Microsoft Copilot, AI-assisted quality management features, process automation tools built on large language models: the adoption curve has accelerated significantly in the past 18 months, and there is no sign of it slowing.

The risk is not the AI itself. The risk is the deployment decisions, and specifically, the decisions that happen when the IT and Quality teams are not in the same conversation before go-live.

Where the Compliance Risk Actually Lives

Most AI deployment conversations in device companies focus on the output question: is the AI generating accurate content, appropriate recommendations, reliable data analysis? That is a legitimate concern, and Quality teams are right to own it.

What gets less attention is the infrastructure question: where does the AI have access? What data can it see, process, or generate from? What gets logged? Who can review what the tool produced, and when?

In a regulated environment, those questions have direct 21 CFR Part 11 implications. If an AI tool assists in generating or modifying a controlled document, the record of that assistance may be part of the audit trail for that document. If AI has access to systems containing regulated records, the scope of that access is an IT controls question, not just a procurement decision.

AI deployment in a regulated environment is not a Quality decision or an IT decision. It is both, and the companies getting it wrong are the ones that have not figured that out yet.

The IT Pre-Deployment Review for AI Tools

Before any AI tool is deployed in an environment where it can touch regulated workflows or regulated data, IT should work through the following:

• Data access scoping. What data sources can the AI tool access? Is it connected to your QMS, your document management system, your ERP? The principle of least privilege applies to AI tools just as it applies to user accounts. The AI should have access to what it needs for its intended use, and nothing more.
• Audit trail implications. If the AI assists in generating or revising a document that ends up in your QMS, is there a record of that assistance? This is not a settled question across the industry, but it is one that Quality and Regulatory need to have explicitly addressed before deployment, not discovered during an audit.
• Access review process. AI tools, especially those integrated with Microsoft 365 or other enterprise platforms, often have broad default access to organizational data. That default access needs to be scoped before deployment through your identity and access management configuration, not after.
• Vendor security documentation. What are the AI vendor's data handling practices? Where is your data processed? What are the retention and deletion policies? These questions matter for any SaaS tool, but they carry additional weight when the tool has access to systems containing regulated records or IP.
• Change management documentation. Deploying an AI tool that connects to systems supporting regulated workflows is a change to those systems' operational environment. That change should go through your documented change management process, even if the AI itself is not a validated system.

The Boundary Between IT and Quality on AI

Quality owns the question of whether AI-generated or AI-assisted content meets the standards for regulated use. IT owns the question of whether the infrastructure supporting that use is configured, documented, and controlled appropriately.

Those are different questions with different owners, and both need to be answered before deployment. The companies that get AI deployment right in regulated environments are not the ones with the most sophisticated AI strategy. They are the ones where IT and Quality sat down together before go-live and worked through the deployment checklist jointly.